{"id":"W4231537586","doi":"10.2165/00128413-200615510-00066","title":"Health Canada has approved rituximab [Rituxan; Roche] as a maintenance therapy for patients with follicular non-Hodgkin's lymphoma","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Oncology; Lymphoma; Hodgkin lymphoma; Maintenance therapy; Internal medicine; Pharmacy; Family medicine; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001180758,0.0004033574,0.0007010312,0.00007512703,0.0002764747,0.00006329269,0.0001504808,0.00007684928,0.00003263398],"category_scores_gemma":[0.00001939046,0.0002869378,0.0001601057,0.0002232092,0.00007462569,0.000102399,0.00002559782,0.00006791065,0.00001866608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001124047,"about_ca_system_score_gemma":0.002384058,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4143664,"about_ca_topic_score_gemma":0.07081407,"domain_scores_codex":[0.9976558,0.00003696792,0.0004352336,0.0005739241,0.0005631758,0.0007349076],"domain_scores_gemma":[0.9986409,0.00008608201,0.0002375718,0.0004297884,0.0002953076,0.0003103663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.006756706,0.01828536,0.265282,0.0003825162,0.001082298,0.0005940069,0.0003360211,0.00002978331,0.0003340501,0.0003673566,0.576034,0.1305159],"study_design_scores_gemma":[0.1144319,0.003714197,0.4590398,0.0002973641,0.0001529007,0.00008453343,0.00008984589,0.0003137593,0.005378974,0.0001256381,0.4157976,0.0005734484],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9776929,0.001247589,0.0002686256,0.01622381,0.0002721245,0.003225157,0.0001928016,0.00008597828,0.0007910046],"genre_scores_gemma":[0.9888663,0.00009615144,0.001650345,0.007198731,0.000217078,0.0008183417,0.0003996986,0.00007621392,0.00067712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3435524,"threshold_uncertainty_score":0.9999583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007872528325920655,"score_gpt":0.2359594050837431,"score_spread":0.2280868767578225,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}